Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2005 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hochheiser, G. M.
Right arrow Articles by Roberts, J. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hochheiser, G. M.
Right arrow Articles by Roberts, J. R.

Surgical Management of Lung Cancer


Monday, October 31, 2005

10:30 AM - 12:00 PM

PARENCHYMA-SPARING SURGERY FOR PROXIMAL NSCLC: SLEEVE RESECTIONS RESULT IN EQUIVALENT SURVIVAL AND BETTER PERFORMANCE THAN PNEUMONECTOMIES

Gary M. Hochheiser, MD*, Maggie C. Oldham and John R. Roberts, MD

Eastern Virginia Medical School, Norfolk, VA

PURPOSE: The perioperative risk after pneumonectomy is high (8-12%) and dramatically decreases a patient’s quality of life, so that parenchyma-sparing procedures are needed. Airway sleeve resections have been described for several decades, but remain rarely done. Arterial sleeve resections are even rarer, and done in only a few centers. We have used airway and arterial sleeve resections commonly, and report a prospective comparison of perioperative complications and survival among airway sleeve resections, arterial sleeve resections, and pneumonectomies.

METHODS: All patients with NSCLC underwent surgical staging prior to resection. At resection patients underwent parenchymal sparing procedures if possible. All patients were resected with negative margins.Survival was compared using nonparametric distribution analysis while differences among means were compared using Student’s t test. Differences in proportions were compared using chi-square. p values <0.05 were considered significant.

RESULTS: Eighty-six patients underwent sleeve resections and 74 patients underwent pneumonectomy. The pneumonectomy patients were younger (58.4 vs 62.7 years) but were otherwise similar. Pneumonectomy patients spent more days in the ICU (3.5 vs. 1.2, p=0.046) but had similar lengths of stay. No difference in overall survival nor in comparisons between node-negative resections (see graph) were found.

CONCLUSION: Sleeve Resections give equivalent survival compared to pneumonectomies and allow preservation of pulmonary parenchyma. With postoperative chemotherapy becoming standard treatment after most hilar resections, preserving lung function, and thus ability to tolerate adjuvant chemotherapy, is more important.

CLINICAL IMPLICATIONS: Sleeve resections allow preservation of lung function and result in equivalent survival.
1-year 2-years 3-years 4-years 5-years

Sleeves 85.70% 72.20% 57.10% 62.50% 50%
Pneumonectomies 93.80% 78.60% 76.90% 53.80% 50%

DISCLOSURE: Gary Hochheiser, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.